Lezack Adam sold BBNX
December 1, 2025 · Form 4 insider transaction
Lezack Adam sold 906 shares of Beta Bionics, Inc. at $29.35 per share, a transaction worth $26.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
906
Price
$29.35
Total value
$26.6K
InsiderLezack Adam
RoleDirector
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 1, 2025
Filing dateDecember 2, 2025
Shares owned after8,935
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025.; The weighted average sale price for the transaction reported was $29.3463 and the range of prices were between $28.75 and $29.63. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.